AUGX
Price:
$2.345
Market Cap:
$115.91M
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquarte...[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
2021-03-31
Stock Exchange
NASDAQ
Ticker
AUGX
According to Augmedix, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.66. This represents a change of -28.76% compared to the average of 2.34 of the last 4 quarters.
The mean historical Current Ratio of Augmedix, Inc. over the last ten years is 2.69. The current 1.66 Current Ratio has changed 6.08% with respect to the historical average. Over the past ten years (40 quarters), AUGX's Current Ratio was at its highest in in the December 2021 quarter at 6.41. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
2.69
Median
2.02
Minimum
1.12
Maximum
6.41
Discovering the peaks and valleys of Augmedix, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 294.68%
Maximum Annual Current Ratio = 6.41
Minimum Annual Increase = -49.88%
Minimum Annual Current Ratio = 1.12
Year | Current Ratio | Change |
---|---|---|
2023 | 2.41 | -25.15% |
2022 | 3.21 | -49.88% |
2021 | 6.41 | 294.68% |
2020 | 1.63 | 45.65% |
2019 | 1.12 | -19.15% |
The current Current Ratio of Augmedix, Inc. (AUGX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.01
5-year avg
2.96
10-year avg
2.69
Augmedix, Inc.’s Current Ratio is less than IN8bio, Inc. (1.84), less than Dermata Therapeutics, Inc. (3.44), less than Elevation Oncology, Inc. (17.77), less than Minerva Surgical, Inc. (1.88), less than Aclarion, Inc. (2.80),
Company | Current Ratio | Market cap |
---|---|---|
1.84 | $18.03M | |
3.44 | $2.20M | |
17.77 | $34.29M | |
1.88 | $888.00 | |
2.80 | $1.30M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Augmedix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Augmedix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Augmedix, Inc.'s Current Ratio?
How is the Current Ratio calculated for Augmedix, Inc. (AUGX)?
What is the highest Current Ratio for Augmedix, Inc. (AUGX)?
What is the 3-year average Current Ratio for Augmedix, Inc. (AUGX)?
What is the 5-year average Current Ratio for Augmedix, Inc. (AUGX)?
How does the current Current Ratio for Augmedix, Inc. (AUGX) compare to its historical average?